skip to main content

H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018

Mar 21, 2018 at 9:53 p.m. ET. On Passage of the Bill in the House.

This was a vote to pass H.R. 5247 (115th) in the House.

H.R. 5247 authorizes the use of eligible investigational drugs by patients who have been diagnosed with certain illnesses, who have exhausted the approved treatment options and are not eligible to participate in a clinical trial.

The bill defines an eligible patient as those with “a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or a disease or condition that would result in significant irreversible morbidity that is likely to lead to severely premature death.”

The legislation allows for investigational drugs to be used if they have completed phase 1 of clinical trials, they have not been approved or licensed for any use under the Public Health Service Act, and an application has been filed that is active under the Public Health Service Act. The legislation removes liability on the manufacturer, sponsor, physician, hospital, or clinical investigator if the above conditions are met and there are not additional factors such as willful, criminal, or reckless misconduct or gross negligence, and removes liability if such an entity makes the determination not to provide the investigational drug. The bill requires doctors for such patients to report “serious adverse events” from the drug to the manufacturer. The legislation also strengthens patients protections with clearer informed consent and real-time adverse event reporting as well as a standard to notify the Food and Drug Administration (FDA) when a patient receives an unapproved drug through the new alternative pathway. The liability protections apply to both the existing expanded access program as well as the new alternative pathway, leveling the playing field by removing a perverse incentive to choose on program over the other.

Source: Republican Policy Committee

Totals

All Votes R D
Aye 64%
 
 
267
232
 
35
 
No 36%
 
 
149
2
 
147
 
Not Voting
 
 
13
3
 
10
 

Passed. Simple Majority Required. Source: house.gov.

Ideology Vote Chart

Key:
Republican - Aye Democrat - Aye Republican - No Democrat - No
Seat position based on our ideology score.

Cartogram Map

Each hexagon represents one congressional district. Solid hexes are Aye votes.

What you can do

Vote Details

Notes: The Speaker’s Vote? “Aye” or “Yea”?
Download as CSV

Statistically Notable Votes

Statistically notable votes are the votes that are most surprising, or least predictable, given how other members of each voter’s party voted and other factors.

All Votes

Study Guide

How well do you understand this vote? Use this study guide to find out.

You can find answers to most of the questions below here on the vote page. For a guide to understanding the bill this vote was about, see here.

What was the procedure for this vote?

  1. What was this vote on?
  2. Not all votes are meant to pass legislation. In the Senate some votes are not about legislation at all, since the Senate must vote to confirm presidential nominations to certain federal positions.

    This vote is related to a bill. However, that doesn’t necessarily tell you what it is about. Congress makes many decisions in the process of passing legislation, such as on the procedures for debating the bill, whether to change the bill before voting on passage, and even whether to vote on passage at all.

    You can learn more about the various motions used in Congress at EveryCRSReport.com. If you aren’t sure what the House was voting on, try seeing if it’s on this list.

  3. What is the next step after this vote?
  4. Take a look at where this bill is in the legislative process. What might come next? Keep in mind what this specific vote was on, and the context of the bill. Will there be amendments? Will the other chamber of Congress vote on it, or let it die?

    For this question it may help to briefly examine the bill itself.

What is your analysis of this vote?

  1. What trends do you see in this vote?
  2. Members of Congress side together for many reasons beside being in the same political party, especially so for less prominent legislation or legislation specific to a certain region. What might have determined how the roll call came out in this case? Does it look like Members of Congress voted based on party, geography, or some other reason?

    One tool that will be helpful in answering this question is the cartogram at the top of the page. A cartogram is a stylized map of the United States that shows each district as an identical hexagon. This view allows you to see the how the representatives from each district voted arranged by their geography and colored by their political party. What trends can you see in the cartogram for this vote?

  3. How did your representative vote?
  4. There is one vote here that should be more important to you than all the others. These are the votes cast by your representative, which is meant to represent you and your community. Do you agree with how your representative voted? Why do you think they voted the way they did?

    If you don’t already know who your Members of Congress are you can find them by entering your address here.

Each vote’s study guide is a little different — we automatically choose which questions to include based on the information we have available about the vote. Study guides are a new feature to GovTrack. You can help us improve them by filling out this survey or by sending your feedback to hello@govtrack.us.